DecisionQ Helps Leading Healthcare and Life Sciences Researchers Uncover Life-Saving Answers Hidden in Their Data
DecisionQ Corporation, a leading provider of predictive analytics software, today announced that top healthcare and life sciences companies are using its FasterAnalytics™ solution in important research efforts that could ultimately save lives. Over the last several months, DecisionQ’s FasterAnalytics software has gained considerable momentum with customers in the healthcare and life sciences industries for its unique ability to predict future outcomes when examining data sets-as opposed to most analytic software packages, which simply use data to describe the past. DecisionQ’s growing list of customers includes: Access Genetics, the Burnham Institute, the Family Violence Prevention Fund, Genentech, Intergenetics, Sharp Healthcare, Sicel Technologies and the University of Mississippi.
Some examples of how DecisionQ has helped these customers gain insights that could advance the treatment of life-threatening diseases such as cancer include:
Access Genetics – Access Genetics is a leader in molecular diagnostics testing for the point of care. Working with DecisionQ, Access Genentics is placing its domain expertise and extensive database to work to develop new models for risk stratification in cervical cancer, enhancing the ability to identify at-risk women early. ·
The Burnham Institute – The Burnham Institute’s mission is to perform outstanding basic research in the life sciences industry. Working with DecisionQ, the Burnham Institute has used its extensive knowledge of gene function, combined with advanced microarray techniques, to develop novel techniques for promoter arrays. ·
Sharp Healthcare – Sharp Healthcare is San Diego’s leading healthcare provider. Working with DecisionQ, Sharp Healthcare has been able to better understand how specific genetic markers combine to predict certain diseases. In addition, they have been able to ascertain how well certain diagnostic tests are able to predict diseases when combined with additional demographic or medical factors. ·
Sicel Technologies – Sicel Technologies is a leading cancer research and technology firm. Working with DecisionQ, Sicel is seeking to gain a better understanding of how treatment effectiveness correlates with specific patient factors such as age, weight, and ethnicity. Based on this data, Sicel hopes to understand which combinations of medical therapy and patient types can lead to the greatest chance of treatment success. ·
University of Mississippi – The University of Mississippi is a leading academic and research institution and is highly respected for its work in the field of health sciences. Working with DecisionQ, the University of Mississippi has been able to better understand which factors lead to medication errors in healthcare institutions.
DecisionQ will be demonstrating FasterAnalytics at this week’s BIO 2004 conference in San Francisco in booth #5344.
About DecisionQ
DecisionQ (www.decisionq.com ) is a leader in predictive analytics software with expertise in the healthcare, lifesciences, and financial services industries. Their FasterAnalytics solution improves the speed and quality of decision-making by allowing customers to quickly turn data into “actionable” insights.
Trademarks: FasterAnalytics is a registered trademark of DecisionQ.
